Source:http://linkedlifedata.com/resource/pubmed/id/12735046
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2003-5-8
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0047-1852
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
61 Suppl 4
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
654-9
|
pubmed:dateRevised |
2011-7-27
|
pubmed:meshHeading |
pubmed-meshheading:12735046-Adrenergic beta-Antagonists,
pubmed-meshheading:12735046-Angina Pectoris,
pubmed-meshheading:12735046-Calcium Channel Blockers,
pubmed-meshheading:12735046-Clinical Trials as Topic,
pubmed-meshheading:12735046-Humans,
pubmed-meshheading:12735046-Isosorbide Dinitrate,
pubmed-meshheading:12735046-Nitroglycerin
|
pubmed:year |
2003
|
pubmed:articleTitle |
[Antianginal drugs].
|
pubmed:affiliation |
Second Department of Internal Medicine, University of Yamanashi Medical School.
|
pubmed:publicationType |
Journal Article,
Review
|